DEPRESSIVE RELAPSE AND LITHOTHERAPY - LOSS OF CHANCE

被引：0
|
作者：
PASCALIS, JG [1 ]
PERCEAU, A [1 ]
BROCHIER, T [1 ]
机构：
[1] HOP ST ANNE,F-75674 PARIS 14,FRANCE
来源：
ANNALES MEDICO-PSYCHOLOGIQUES | 1993年 / 151卷 / 07期
关键词：
ANTIDEPRESSANT; DEPRESSIVE RECURRENT; LITHIUM; LOSS OF CHANCE; MANIC-DEPRESSIVE PSYCHOSIS;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
By four patients hospitalized for a depressive recurrent the favorable element of clinic evolution wa a lithotherapy then bring the effect very rapidly (three to seven days) grace using gluconate of lithium. The lithium being antidepressant, the absence of lithotherapy tentative in the course of major depressive status recurrent is a loss of chance for patients.
引用
收藏
页码：510 / 511
页数：2
相关论文
共 33 条
  • [21] Relapse prevention in recurrent major depressive disorder. A comparison of different treatment options based on clinical experience and a critical review of the literature
    Cosci, Fiammetta
    Mansueto, Giovanni
    Fava, Giovanni Andrea
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2020, 24 (04) : 341 - 348
  • [22] Relapse prevention with levomilnacipran ER in adults with major depressive disorder: A multicenter, randomized, double-blind, placebo-controlled study
    Durgam, Suresh
    Chen, Changzheng
    Migliore, Raffaele
    Prakash, Chandran
    Thase, Michael E.
    DEPRESSION AND ANXIETY, 2019, 36 (03) : 225 - 234
  • [23] Predictors of relapse in patients with major depressive disorder in a 52-week, fixed dose, double blind, randomized trial of selegiline transdermal system (STS)
    Jang, Saeheon
    Jung, Sungwon
    Pae, Chiun
    Portland, Kimberly Blanchard
    Nelson, J. Craig
    Patkar, Ashwin A.
    JOURNAL OF AFFECTIVE DISORDERS, 2013, 151 (03) : 854 - 859
  • [24] The Loss of Chance Doctrine and current changes in the practice and views of courts of justice on the principles of causality and causal link in civil medico-legal proceedings
    Pinos, I
    ANESTEZIOLOGIE A INTENZIVNI MEDICINA, 2016, 27 (01): : 46 - 49
  • [25] Late Administration of Trastuzumab Emtansine Might Lead to Loss of Chance for Better Outcome in Patients with HER2-Positive Metastatic Breast Cancer
    Manso, Luis
    Sanchez-Munoz, Alfonso
    Calvo, Isabel
    Izarzugaza, Yann
    Plata, Jessica
    Rodriguez, Cesar
    BREAST CARE, 2018, 13 (04) : 277 - 283
  • [26] A novel study design for investigating relapse prevention in major depressive disorder: Preliminary data from the open-label period of a phase 4 vortioxetine study
    Jacobsen, Paula
    Zhong, Wei
    Xu, Rengyi
    Nomikos, George
    JOURNAL OF AFFECTIVE DISORDERS, 2020, 266 : 173 - 181
  • [27] The emergence of loss of efficacy during antidepressant drug treatment for major depressive disorder: An integrative review of evidence, mechanisms, and clinical implications
    Fornaro, Michele
    Anastasia, Annalisa
    Novello, Stefano
    Fusco, Andrea
    Pariano, Riccardo
    De Berardis, Domenico
    Solmi, Marco
    Veronese, Nicola
    Stubbs, Brendon
    Vieta, Eduard
    Berk, Michael
    de Bartolomeis, Andrea
    Carvalho, Andre F.
    PHARMACOLOGICAL RESEARCH, 2019, 139 : 494 - 502
  • [28] Update to the study protocol for a randomized controlled trial comparing mindfulness-based cognitive therapy with maintenance anti-depressant treatment depressive relapse/recurrence: the PREVENT trial
    Kuyken, Willem
    Byford, Sarah
    Byng, Richard
    Dalgleish, Tim
    Lewis, Glyn
    Taylor, Rod
    Watkins, Edward R.
    Hayes, Rachel
    Lanham, Paul
    Kessler, David
    Morant, Nicola
    Evans, Alison
    TRIALS, 2014, 15
  • [29] Depressive relapse during lithium treatment associated with increased serum thyroid-stimulating hormone: results from two placebo-controlled bipolar I maintenance studies
    Frye, M. A.
    Yatham, L.
    Ketter, T. A.
    Goldberg, J.
    Suppes, T.
    Calabrese, J. R.
    Bowden, C. L.
    Bourne, E.
    Bahn, R. S.
    Adams, B.
    ACTA PSYCHIATRICA SCANDINAVICA, 2009, 120 (01) : 10 - 13
  • [30] Update to the study protocol for a randomized controlled trial comparing mindfulness-based cognitive therapy with maintenance anti-depressant treatment depressive relapse/recurrence: the PREVENT trial
    Willem Kuyken
    Sarah Byford
    Richard Byng
    Tim Dalgleish
    Glyn Lewis
    Rod Taylor
    Edward R Watkins
    Rachel Hayes
    Paul Lanham
    David Kessler
    Nicola Morant
    Alison Evans
    Trials, 15
1234